HIPEC for gynaecological malignancies: A last update (Review).

Med Int (Lond) · 2023 · PMC10189421 · PMID 37205988

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an increasing trendno p-value reported

Conclusions and future perspectives Over the past few years, the use of HIPEC following CRS for the treatment of peritoneal malignancies has exhibited an increasing trend.

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.